Jonathan Sheena - Apr 20, 2023 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
Director, CO-FOUNDER
Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Apr 20, 2023
Transactions value $
-$18,091
Form type
4
Date filed
4/24/2023, 09:35 PM
Previous filing
Apr 5, 2023
Next filing
May 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise +190 +0.04% 525K Apr 20, 2023 Direct F1
transaction NTRA Common Stock Sale -$3.09K -57 -0.01% $54.27 525K Apr 21, 2023 Direct F2
transaction NTRA Common Stock Sale -$12.6K -233 -0.04% $54.22 525K Apr 21, 2023 Direct F3, F4
transaction NTRA Common Stock Options Exercise +143 +0.03% 525K Apr 21, 2023 Direct F1
transaction NTRA Common Stock Sale -$2.36K -43 -0.01% $54.98 525K Apr 24, 2023 Direct F2
holding NTRA Common Stock 25.2K Apr 20, 2023 By Caraluna Trust 1 F5
holding NTRA Common Stock 25.2K Apr 20, 2023 By Caraluna Trust 2 F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Restricted Stock Unit Options Exercise $0 -190 -8.32% $0.00 2.09K Apr 20, 2023 Common Stock 190 Direct F1, F6
transaction NTRA Restricted Stock Unit Options Exercise $0 -143 -12.49% $0.00 1K Apr 21, 2023 Common Stock 143 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.
F3 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.1950 to $54.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.
F6 The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.
F7 The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter